We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Biotech and Pharma Execs, Patient Groups and Payers to Discuss Strategies to Expedite Orphan Drug Access
News

Biotech and Pharma Execs, Patient Groups and Payers to Discuss Strategies to Expedite Orphan Drug Access

Biotech and Pharma Execs, Patient Groups and Payers to Discuss Strategies to Expedite Orphan Drug Access
News

Biotech and Pharma Execs, Patient Groups and Payers to Discuss Strategies to Expedite Orphan Drug Access

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Biotech and Pharma Execs, Patient Groups and Payers to Discuss Strategies to Expedite Orphan Drug Access"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Come April 10-13, over 300 key decision makers from orphan drug manufacturers, patient groups, payers and regulators will gather in DC at the 2nd annual World Orphan Drug Congress USA. Key speakers include Mike Astrue, Commissioner of the US Social Security Administration;  Angus Russell, CEO of Shire, Yi-Ou Wang, Founder & President of China-Dolls Care and Support Association and Dr. Duraiswamy Navaneetham, Director of the Foundation for Research on Rare Diseases and Disorders India.

This event is designed to help biotech and pharma find new ways to expedite orphan drugs to patients, whether by partnering with new and innovative technology, streamlining clinical development, globalizing patient registry, eliminating manufacturing bottlenecks, reaching out to patients through targeted social media marketing or by guaranteeing and fast-tracking reimbursement.  

Co-located with the World Pediatric Drugs Congress this event will be the premier event you need to go to in 2012!

Participants will learn:
•    How to successfully launch an orphan drug
•    How to guarantee and fast track reimbursement
•    How to navigate through Health Reforms, HTAs and CERs
•    How to engage patients and reach out to decision makers through targeted social media marketing
•    How to articulate orphan drugs value proposition to various stakeholders

Advertisement